For instance, in head and neck squamous cell carcinoma (HNSCC), the depletion of ATG12 leads to a diminished autophagic flux, which subsequently inhibits the proliferation of cancer cells and enhances their susceptibility to chemotherapeutic agents 34. This evidence concerns the gene ATG12 and head and neck squamous cell carcinoma.